195 related articles for article (PubMed ID: 12649095)
1. Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes.
Cella D; Dobrez D; Glaspy J
Ann Oncol; 2003 Apr; 14(4):511-9. PubMed ID: 12649095
[TBL] [Abstract][Full Text] [Related]
2. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
4. Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa.
Valley AW
Pharmacotherapy; 2002 Sep; 22(9 Pt 2):150S-159S. PubMed ID: 12222585
[TBL] [Abstract][Full Text] [Related]
5. Darbepoetin alfa: a review of its use in the treatment of anaemia in patients with cancer receiving chemotherapy.
Siddiqui MA; Keating GM
Drugs; 2006; 66(7):997-1012. PubMed ID: 16740021
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
7. Darbepoetin alfa: a novel erythropoiesis-stimulating protein.
Cases A
Drugs Today (Barc); 2003 Jul; 39(7):477-95. PubMed ID: 12973399
[TBL] [Abstract][Full Text] [Related]
8. Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting.
Gascón P
Eur J Cancer; 2005 Nov; 41(17):2601-12. PubMed ID: 16230006
[TBL] [Abstract][Full Text] [Related]
9. Darbepoetin alfa for the treatment of cancer-related anemia: an update.
Pirker R
Expert Rev Anticancer Ther; 2004 Oct; 4(5):735-44. PubMed ID: 15485310
[TBL] [Abstract][Full Text] [Related]
10. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review.
Ross SD; Fahrbach K; Frame D; Scheye R; Connelly JE; Glaspy J
Clin Ther; 2003 Jun; 25(6):1786-805. PubMed ID: 12860499
[TBL] [Abstract][Full Text] [Related]
11. Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.
Stasi R; Amadori S; Littlewood TJ; Terzoli E; Newland AC; Provan D
Oncologist; 2005 Aug; 10(7):539-54. PubMed ID: 16079321
[TBL] [Abstract][Full Text] [Related]
12. Anemia in cancer patients: significance, epidemiology, and current therapy.
Tchekmedyian NS
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):17-24. PubMed ID: 12380951
[TBL] [Abstract][Full Text] [Related]
13. Treatment of anemia in patients with chronic heart failure.
Katz SD; Mancini D; Androne AS; Hryniewicz K
J Card Fail; 2004 Feb; 10(1 Suppl):S13-6. PubMed ID: 15007795
[TBL] [Abstract][Full Text] [Related]
14. Darbepoetin alfa: potential role in managing anemia in cancer patients.
Pirker R; Smith R
Expert Rev Anticancer Ther; 2002 Aug; 2(4):377-84. PubMed ID: 12647980
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.
Charu V; Belani CP; Gill AN; Bhatt M; Tomita D; Rossi G; Ben-Jacob A
Oncologist; 2007 Jun; 12(6):727-37. PubMed ID: 17602062
[TBL] [Abstract][Full Text] [Related]
16. Practitioners' practical model for managing cancer-related anemia.
Smith RE; Tchekmedyian S
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):55-63. PubMed ID: 12380955
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
18. The relationship between patient knowledge of hemoglobin levels and health-related quality of life.
Kallich J; McDermott A; Xu X; Fayers P; Cella D
Qual Life Res; 2006 Feb; 15(1):57-68. PubMed ID: 16411031
[TBL] [Abstract][Full Text] [Related]
19. Association of anemia correction with health related quality of life in patients not on dialysis.
Alexander M; Kewalramani R; Agodoa I; Globe D
Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
[TBL] [Abstract][Full Text] [Related]
20. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
